| Literature DB >> 25984722 |
Carrie S McLean1, Clinton Mielke1, Jeanine M Cordova1, Paul R Langlais2, Benjamin Bowen1, Danielle Miranda2, Dawn K Coletta1, Lawrence J Mandarino3.
Abstract
BACKGROUND: Healthy individuals on the lower end of the insulin sensitivity spectrum also have a reduced gene expression response to exercise for specific genes. The goal of this study was to determine the relationship between insulin sensitivity and exercise-induced gene expression in an unbiased, global manner. METHODS ANDEntities:
Mesh:
Substances:
Year: 2015 PMID: 25984722 PMCID: PMC4436215 DOI: 10.1371/journal.pone.0127089
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Overall design of the study.
The overall sequence of study days is shown above an expanded view of the acute exercise bout. During the acute exercise bout, subjects exercise for a total of 48 minutes, consisting of 4 sets of exercise, each set consisting of 8 minutes at 70% HR max, 2 minutes at 90% HR max, and 2 minutes of rest. A biopsy of the vastus lateralis muscle was taken at 30 minutes after completing the four sets of exercise. Bx, Biopsy; VO2, rate of oxygen consumption; HR, Heart Rate.
Participant characteristics.
| Total | Median (range) | miRNA subset | Median (range) | |
|---|---|---|---|---|
| Sex | 9M/5F | 5M/1F | ||
| Age (years) | 33 ± 2 | 33 (23–48) | 33 ± 3 | 31 (26–48) |
| Body Mass Index (Kg/m2) | 27.2 ± 0.8 | 26.5 (22.1–34.2) | 27.2 ± 0.7 | 26.7 (25.5–29.9) |
| Body fat (%) | 25.5 ± 1.3 | 26.2 (15–34) | 22.0 ± 1.7 | 22.2 (15–26.2) |
| Fasting plasma glucose (mM) | 5.00 ± 0.06 | 5.00 (4.5–5.4) | 4.99 ± 0.05 | 4.94 (4.9–5.2) |
| HbA1c (%) | 5.4 ± 0.1 | 5.5 (4.9–5.8) | 5.4 ± 0.2 | 5.4 (4.9–5.8) |
| Cholesterol (mg/dL) | 177 ± 6 | 176 (145–213) | 171 ± 10 | 161 (145–206) |
| HDL Cholesterol (mg/dL) | 50.3 ± 3.4 | 47.5 (33–84) | 44.7 ± 1.9 | 44 (40–52) |
| LDL Cholesterol (mg/dL) | 106 ± 4 | 107 (80–146) | 101 ± 5 | 97 (87–117) |
| VLDL Cholesterol (mg/dL) | 20 ± 3 | 16 (7–43) | 25 ± 6 | 22 (7–43) |
| Triglycerides (mg/dL) | 118 ± 17 | 96 (44–258) | 148 ± 32 | 133 (44–258) |
| Fasting plasma insulin (pM) | 41 ± 7 | 35 (11–100) | 44 ± 13 | 33 (11–100) |
| Clamp plasma insulin (pM) | 944 ± 58 | 912 (684–1434) | 878 ± 81 | 87 (684–1068) |
| Insulin stimulated glucose disposal (mg·Kg FFM-1·min-1) | 9.3 ± 0.8 | 8.9 (5.2–13.3) | 9.7 ± 1.2 | 8.9 (6.1–13.3) |
| VO2peak (ml·Kg FFM-1·min-1) | 43.8 ± 2.1 | 42.8 (31.9–58.3) | 43.3 ± 3.4 | 41.8 (34.2–58.4) |
| Resting Heart Rate (BPM) | 65 ± 2 | 66 (58–76) | 64 ± 2 | 64 (58–71) |
| Peak Heart Rate (BPM) actual(predicted) | 184 ± 2(187 ± 2) | 184 (172–199) | 181 ± 2(187 ± 2) | 177 (173–199) |
| 70% Heart Rate (BPM) actual(predicted) | 138 ± 2 | 136 (123–159) | 137 ± 4 | 135 (123–152) |
| 90% Heart Rate (BPM) actual(predicted) | 162 ± 3(166 ± 2) | 160 (144–179) | 160 ± 3(162 ± 4) | 160 (150–169) |
| Maximum Work (Watts) | 175 ± 18 | 175 (100–260) | 198 ± 18 | 200 (125–260) |
Data are given as Mean ± SEM. The six volunteers in the miRNA subset are included in the total group of 14. Data are shown as Mean ± SEM. Peak heart rate was highest value achieved during the VO2peak determination. Maximum predicted heart rate = 220—age.
*P<0.05,
**P < 0.01 vs. predicted value.
Kg, kilograms; mg, milligrams; dL, deciliter; pM, picomolar; FFM, fat free mass; BPM, beats per minute.
Fig 2Relationships among response of genes (at the probe level) to exercise and insulin sensitivity.
Shown are exercise-induced fold changes in expression for the indicated genes plotted against rates of insulin-stimulated glucose disposal during a euglycemic, hyperinsulinemic clamp. P values displayed for correlations were corrected using the Benjamini Hochberg method.
miRNA species changing significantly 30 minutes after exercise.
| Mature miRNA | Precursor | Basal | Post Exercise | Log2(fold increase) |
|---|---|---|---|---|
| hsa-miR-10a-5p | hsa-mir-10a | 807 ± 120 | 1056 ± 134 | 0.408 ± 0.101 |
| hsa-miR-30a-5p | hsa-mir-30a | 3548 ± 456 | 5155 ± 327 | 0.570 ± 0.102 |
| hsa-miR-30d-5p | hsa-mir-30d | 4431 ± 454 | 6425 ± 595 | 0.541 ± 0.127 |
| hsa-miR-22-3p | hsa-mir-22 | 7681 ± 948 | 14180 ± 1839 | 0.888 ± 0.191 |
| hsa-miR-128 | hsa-mir-128-1 | 1593 ± 173 | 3393 ± 685 | 1.027 ± 0.206 |
| hsa-miR-128 | hsa-mir-128-2 | 905 ± 101 | 1941 ± 410 | 1.022 ± 0.235 |
| hsa-miR-378a-3p | hsa-mir-378a | 24843 ± 3181 | 40779 ± 7614 | 0.688 ± 0.169 |
| hsa-miR-378f | hsa-mir-378f | 148 ± 24 | 244 ± 39 | 0.726 ± 0.162 |
| hsa-miR-378a-5p | hsa-mir-378a | 361 ± 36 | 528 ± 36 | 0.561 ± 0.145 |
| hsa-miR-378g | hsa-mir-378g | 75 ± 16 | 117 ± 32 | 0.611 ± 0.160 |
| hsa-miR-378i | hsa-mir-378i | 1550 ± 230 | 2690 ± 542 | 0.768 ± 0.210 |
| hsa-miR-422a | hsa-mir-422a | 74 ± 16 | 124 ± 36 | 0.689 ± 0.163 |
| hsa-miR-532-5p | hsa-mir-532 | 298 ± 59 | 682 ± 152 | 1.160 ± 0.339 |
Data are given as Means ± SEM, units are number of specific reads normalized to total reads for a given sample. All changes shown for log2(fold stimulation) are P < 0.0004 or less (Bonferroni correction to keep family-wise error rate at 0.05).